Evolutionary Genomics, Inc. (FNAM)

USD 0.0

(0.0%)

Revenue Summary of Evolutionary Genomics, Inc.

  • Evolutionary Genomics, Inc.'s latest annual revenue in 2022 was - USD , down 0.0% from previous year.
  • Evolutionary Genomics, Inc.'s latest quarterly revenue in 2023 Q2 was - USD , down 0.0% from previous quarter.
  • Evolutionary Genomics, Inc. reported a annual revenue of - USD in annual revenue 2021, down -100.0% from previous year.
  • Evolutionary Genomics, Inc. reported a annual revenue of 12.5 Thousand USD in annual revenue 2020, down -89.81% from previous year.
  • Evolutionary Genomics, Inc. reported a quarterly revenue of - USD for 2023 Q1, down 0.0% from previous quarter.
  • Evolutionary Genomics, Inc. reported a quarterly revenue of - USD for 2023 Q2, down 0.0% from previous quarter.

Annual Revenue Chart of Evolutionary Genomics, Inc. (2022 - 2009)

Historical Annual Revenue of Evolutionary Genomics, Inc. (2022 - 2009)

Year Revenue Revenue Growth
2022 - USD 0.0%
2021 - USD -100.0%
2020 12.5 Thousand USD -89.81%
2019 122.68 Thousand USD 6.86%
2018 114.81 Thousand USD 251.22%
2017 32.69 Thousand USD -85.25%
2016 221.58 Thousand USD -15.72%
2015 262.92 Thousand USD -24.45%
2014 348.03 Thousand USD -56.44%
2013 799.02 Thousand USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%

Peer Revenue Comparison of Evolutionary Genomics, Inc.

Name Revenue Revenue Difference
America Great Health 204.3 Thousand USD 100.0%
Gene Biotherapeutics, Inc. - USD NaN%
Innovation1 Biotech Inc. - USD NaN%
Point of Care Nano-Technology, Inc. - USD NaN%
Vicapsys Life Sciences, Inc. - USD NaN%